Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

  • STATUS
    Recruiting
  • participants needed
    300
  • sponsor
    Vivozon, Inc.
Updated on 16 February 2024
postoperative pain
analgesics
internal fixation
bunionectomy

Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.

Details
Condition Postoperative pain
Age 18years - 100years
Treatment Placebo, VVZ-149 Injections
Clinical Study IdentifierNCT04430088
SponsorVivozon, Inc.
Last Modified on16 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Men and women must be at least 18 years of age. Female subjects must meet additional criteria in relation to childbearing potential
Subjects must be undergoing a planned first metatarsal bunionectomy with osteotomy and internal fixation (Austin bunionectomy) without collateral procedures
Subjects must have the ability to provide written informed consent
Subjects must have the ability to understand study procedures and communicate clearly with the Investigator and staff

Exclusion Criteria

Subjects undergoing emergency or unplanned surgery
Subjects who had any previous bunionectomy procedure on either foot
Subjects with pre-existing conditions (other than bunion) causing preoperative pain at the site of surgery
Female subjects who are pregnant or breastfeeding
Diagnosis of chronic pain and ongoing or frequent use of pain medications
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.